Ligand validation:3CIX

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 3CIX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CIX_SAH_A_1501	97%	26%	0.052	0.964	1.09	1.89	2	3	0	0	100%	1
4JYF_SAH_A_402	99%	25%	0.046	0.978	1.06	1.95	1	3	1	0	100%	1
5FF3_SAH_A_410	99%	29%	0.053	0.981	1.32	1.5	2	4	0	0	100%	1
8QMM_SAH_A_402	98%	56%	0.056	0.982	0.68	1.01	-	-	0	0	100%	0.74
4JY9_SAH_A_402	98%	29%	0.056	0.978	1.29	1.55	4	4	0	0	100%	1
5FF4_SAH_A_408	97%	27%	0.057	0.97	1.29	1.64	3	3	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.